Cargando…
Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)
Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70–82 years with a history...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527505/ https://www.ncbi.nlm.nih.gov/pubmed/23285043 http://dx.doi.org/10.1371/journal.pone.0052438 |
_version_ | 1782253738072735744 |
---|---|
author | Poortvliet, Rosalinde K. E. Ford, Ian Lloyd, Suzanne M. Sattar, Naveed Mooijaart, Simon P. de Craen, Anton J. M. Westendorp, Rudi G. J. Jukema, J. Wouter Packard, Christopher J. Gussekloo, Jacobijn de Ruijter, Wouter Stott, David J. |
author_facet | Poortvliet, Rosalinde K. E. Ford, Ian Lloyd, Suzanne M. Sattar, Naveed Mooijaart, Simon P. de Craen, Anton J. M. Westendorp, Rudi G. J. Jukema, J. Wouter Packard, Christopher J. Gussekloo, Jacobijn de Ruijter, Wouter Stott, David J. |
author_sort | Poortvliet, Rosalinde K. E. |
collection | PubMed |
description | Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70–82 years with a history of, or risk factors for cardiovascular disease. Visit-to-visit variability in blood pressure (standard deviation) was determined using a minimum of five measurements over 1 year; an inception cohort of 4819 subjects had subsequent in-trial 3 years follow-up; longer-term follow-up (mean 7.1 years) was available for 1808 subjects. Higher systolic blood pressure variability independently predicted long-term follow-up vascular and total mortality (hazard ratio per 5 mmHg increase in standard deviation of systolic blood pressure = 1.2, 95% confidence interval 1.1–1.4; hazard ratio 1.1, 95% confidence interval 1.1–1.2, respectively). Variability in diastolic blood pressure associated with increased risk for coronary events (hazard ratio 1.5, 95% confidence interval 1.2–1.8 for each 5 mmHg increase), heart failure hospitalisation (hazard ratio 1.4, 95% confidence interval 1.1–1.8) and vascular (hazard ratio 1.4, 95% confidence interval 1.1–1.7) and total mortality (hazard ratio 1.3, 95% confidence interval 1.1–1.5), all in long-term follow-up. Pulse pressure variability was associated with increased stroke risk (hazard ratio 1.2, 95% confidence interval 1.0–1.4 for each 5 mmHg increase), vascular mortality (hazard ratio 1.2, 95% confidence interval 1.0–1.3) and total mortality (hazard ratio 1.1, 95% confidence interval 1.0–1.2), all in long-term follow-up. All associations were independent of respective mean blood pressure levels, age, gender, in-trial treatment group (pravastatin or placebo) and prior vascular disease and cardiovascular disease risk factors. Our observations suggest variability in diastolic blood pressure is more strongly associated with vascular or total mortality than is systolic pressure variability in older high-risk subjects. |
format | Online Article Text |
id | pubmed-3527505 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-35275052013-01-02 Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) Poortvliet, Rosalinde K. E. Ford, Ian Lloyd, Suzanne M. Sattar, Naveed Mooijaart, Simon P. de Craen, Anton J. M. Westendorp, Rudi G. J. Jukema, J. Wouter Packard, Christopher J. Gussekloo, Jacobijn de Ruijter, Wouter Stott, David J. PLoS One Research Article Variability in blood pressure predicts cardiovascular disease in young- and middle-aged subjects, but relevant data for older individuals are sparse. We analysed data from the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) study of 5804 participants aged 70–82 years with a history of, or risk factors for cardiovascular disease. Visit-to-visit variability in blood pressure (standard deviation) was determined using a minimum of five measurements over 1 year; an inception cohort of 4819 subjects had subsequent in-trial 3 years follow-up; longer-term follow-up (mean 7.1 years) was available for 1808 subjects. Higher systolic blood pressure variability independently predicted long-term follow-up vascular and total mortality (hazard ratio per 5 mmHg increase in standard deviation of systolic blood pressure = 1.2, 95% confidence interval 1.1–1.4; hazard ratio 1.1, 95% confidence interval 1.1–1.2, respectively). Variability in diastolic blood pressure associated with increased risk for coronary events (hazard ratio 1.5, 95% confidence interval 1.2–1.8 for each 5 mmHg increase), heart failure hospitalisation (hazard ratio 1.4, 95% confidence interval 1.1–1.8) and vascular (hazard ratio 1.4, 95% confidence interval 1.1–1.7) and total mortality (hazard ratio 1.3, 95% confidence interval 1.1–1.5), all in long-term follow-up. Pulse pressure variability was associated with increased stroke risk (hazard ratio 1.2, 95% confidence interval 1.0–1.4 for each 5 mmHg increase), vascular mortality (hazard ratio 1.2, 95% confidence interval 1.0–1.3) and total mortality (hazard ratio 1.1, 95% confidence interval 1.0–1.2), all in long-term follow-up. All associations were independent of respective mean blood pressure levels, age, gender, in-trial treatment group (pravastatin or placebo) and prior vascular disease and cardiovascular disease risk factors. Our observations suggest variability in diastolic blood pressure is more strongly associated with vascular or total mortality than is systolic pressure variability in older high-risk subjects. Public Library of Science 2012-12-20 /pmc/articles/PMC3527505/ /pubmed/23285043 http://dx.doi.org/10.1371/journal.pone.0052438 Text en © 2012 Poortvliet et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Poortvliet, Rosalinde K. E. Ford, Ian Lloyd, Suzanne M. Sattar, Naveed Mooijaart, Simon P. de Craen, Anton J. M. Westendorp, Rudi G. J. Jukema, J. Wouter Packard, Christopher J. Gussekloo, Jacobijn de Ruijter, Wouter Stott, David J. Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
title | Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
title_full | Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
title_fullStr | Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
title_full_unstemmed | Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
title_short | Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) |
title_sort | blood pressure variability and cardiovascular risk in the prospective study of pravastatin in the elderly at risk (prosper) |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527505/ https://www.ncbi.nlm.nih.gov/pubmed/23285043 http://dx.doi.org/10.1371/journal.pone.0052438 |
work_keys_str_mv | AT poortvlietrosalindeke bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT fordian bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT lloydsuzannem bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT sattarnaveed bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT mooijaartsimonp bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT decraenantonjm bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT westendorprudigj bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT jukemajwouter bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT packardchristopherj bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT gussekloojacobijn bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT deruijterwouter bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper AT stottdavidj bloodpressurevariabilityandcardiovascularriskintheprospectivestudyofpravastatinintheelderlyatriskprosper |